Rivastigmine Hydrogen Tartrate

Rivastigmine Hydrogen Tartrate API (CAS No: 129101-54-8) is carefully manufactured by Amber Lifesciences Pvt. Ltd. in world-class GMP and ISO 9001:2015 certified production facilities, ensuring superior purity, consistent batch quality, and adherence to international regulatory guidelines. Each production lot is accompanied by a detailed Certificate of Analysis (COA) and Material Safety Data Sheet (MSDS), compliant with USP/EP pharmacopeial standards.

Rivastigmine Hydrogen Tartrate is an acetylcholinesterase inhibitor used primarily in the management of mild to moderate dementia associated with Alzheimer’s and Parkinson’s diseases. It enhances cholinergic function by increasing the concentration of acetylcholine through reversible inhibition of its hydrolysis. Our API undergoes strict quality assurance and validated production processes to ensure excellent performance in pharmaceutical formulations.

Amber Lifesciences supports pharmaceutical manufacturers, exporters, traders, and formulation partners across Asia, Europe, the Middle East, and LATAM regions, offering reliable supply chains, technical support, and comprehensive regulatory documentation to ensure seamless product registration and efficient market entry.

Storage & Transportation

Classified as non-Dangerous Goods. Store at controlled room temperature (20°C to 25°C / 68°F to 77°F), protected from light, moisture, and excessive heat. Handle according to standard pharmaceutical transportation and storage guidelines.